Public Equities L.P. Invus's Net Worth
Public Equities L.P. Invus's net worth is estimated to be at least $98,546,564.14 as of 12/22/2024. CoreStreet's estimation of Public Equities L.P. Invus's net worth is based on their sale of stock and current holding of stock.
Public Equities L.P. Invus is Major Shareholder at Scholar Rock Holding Corp. They have executed at least 34 trades of stock as per SEC Form 4 filings. Their most recent trade was for 409,433 units of SRRK stock on 11/25/2024. Their biggest sale was on 02/01/2021 when they sold 252,545 units of Seer Inc stock for $16,200,761.75. They typically trade 4 times per year.
Total value of insider buys:
- $66,370,695.65
Total value of insider sells:
- $32,175,868.49
Most recent insider trade:
- Nov. 25, 2024
Public Equities L.P. Invus's Insider Trading History
| Scholar Rock Holding Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 25, 2024 | Major Shareholder | 409,433 | $38.49 | Sell | $15,759,076.17 |
Oct. 12, 2023 | Major Shareholder | 2,199,931 | $6.86 | Buy | $15,091,526.66 |
April 28, 2023 | Major Shareholder | 31,557 | $6.43 | Buy | $202,911.51 |
Jan. 9, 2023 | Major Shareholder | 1,094 | $9.48 | Sell | $10,371.12 |
Jan. 5, 2023 | Major Shareholder | 48,774 | $9.33 | Buy | $455,061.42 |
Oct. 25, 2022 | Major Shareholder | 130,265 | $8.04 | Buy | $1,047,330.60 |
Oct. 3, 2022 | Major Shareholder | 33,971 | $7.03 | Buy | $238,816.13 |
| GlycoMimetics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 7, 2024 | Major Shareholder | 61,488 | $0.18 | Sell | $11,067.84 |
Aug. 5, 2024 | Major Shareholder | 164,523 | $0.19 | Sell | $31,259.37 |
Aug. 1, 2024 | Major Shareholder | 63,564 | $0.22 | Sell | $13,984.08 |
July 29, 2024 | Major Shareholder | 363,949 | $0.24 | Sell | $87,347.76 |
July 26, 2024 | Major Shareholder | 258,335 | $0.24 | Sell | $62,000.40 |
Feb. 23, 2023 | Major Shareholder | 200,000 | $1.75 | Buy | $350,000.00 |
Feb. 21, 2023 | Major Shareholder | 50,000 | $1.85 | Buy | $92,500.00 |
Feb. 17, 2023 | Major Shareholder | 200,000 | $1.71 | Buy | $342,000.00 |
Feb. 15, 2023 | Major Shareholder | 1,000,000 | $2.16 | Buy | $2,160,000.00 |
Feb. 9, 2023 | Major Shareholder | 11,451 | $3.24 | Buy | $37,101.24 |
| Seer Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 1, 2021 | Major Shareholder | 252,545 | $64.15 | Sell | $16,200,761.75 |
Dec. 8, 2020 | Major Shareholder | 790,000 | $19.00 | Buy | $15,010,000.00 |
| Lexicon Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 28, 2018 | Director | 182,838 | $12.51 | Buy | $2,287,303.38 |
June 25, 2018 | Director | 253,725 | $12.99 | Buy | $3,295,887.75 |
June 21, 2018 | Director | 72,973 | $13.29 | Buy | $969,811.17 |
June 18, 2018 | Director | 45,784 | $12.98 | Buy | $594,276.32 |
June 14, 2018 | Director | 9,200 | $12.66 | Buy | $116,472.00 |
June 11, 2018 | Director | 98,626 | $12.75 | Buy | $1,257,481.50 |
June 8, 2018 | Director | 29,747 | $12.89 | Buy | $383,438.83 |
June 6, 2018 | Director | 95,079 | $12.58 | Buy | $1,196,093.82 |
June 4, 2018 | Director | 416,481 | $12.01 | Buy | $5,001,936.81 |
June 1, 2018 | Director | 147,339 | $12.22 | Buy | $1,800,482.58 |
May 30, 2018 | Director | 433,378 | $9.94 | Buy | $4,307,777.32 |
May 25, 2018 | Director | 138,700 | $9.62 | Buy | $1,334,294.00 |
Nov. 17, 2017 | Director | 180,727 | $10.11 | Buy | $1,827,149.97 |
Nov. 14, 2017 | Director | 575,946 | $9.64 | Buy | $5,552,119.44 |
Nov. 10, 2017 | Director | 145,680 | $9.74 | Buy | $1,418,923.20 |